Asia Pacific Gene Expression Market Report and Forecast 2025-2034

Asia Pacific Gene Expression Market Outlook

The global gene expression market size was valued at USD 13.3 billion in 2024, with Asia Pacific holding a significant market share. It is driven by the growing demand for personalized medicine in the region. The market is expected to grow at a CAGR of 10.4% during the forecast period of 2025-2034, with the values likely attain USD 32.4 billion by 2034.

Key Takeaways

• Growth in cancer incidence along with other chronic diseases wherein gene expression may contribute as an effective treatment alternative is a significant factor boosting the market growth.

• The Asia Pacific gene expression market share is propelled by increasing adoption of innovative technologies. Milner Therapeutics Institute (MTI) at the University of Cambridge and AstraZeneca partnered in November 2023, to understand the genomic relationship with chronic diseases by using technologies like CRISPR.

• The market value is driven by increasing incidence of collaborations and acquisitions to develop and implement best resources in the region. In May 2023, Pfizer, and Thermo Fisher Scientific Inc., collaborated to provide local access to NGS test for lung and breast cancer patients in over 30 countries.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Asia Pacific Gene Expression Market Analysis

Gene expression is a process by which information encoded in a gene is used in the synthesis of a functional gene product which enables to produce proteins or end products. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing among others. Asia Pacific is accountable for 50% of the overall new cancer cases worldwide. The cancer associated mortality rate is likely to increase by 36% in the coming years. With a deeper understanding of human physiology and rising burden of chronic illnesses like cancer and other rare diseases, gene expression finds its application in multiple medical domains. Consequently, the Asia Pacific gene expression market demand has witness growth in recent years.

In May 2023, Thermo Fisher Scientific Inc. and Pfizer entered into a collaboration agreement with an aim to enhance the local access to next-generation sequencing (NGS) tests for breast and lung cancer patients across several countries. The initiative was specifically aimed at regions where advanced genomic testing had been unavailable or limited. The access to NGS testing provides quicker gene analysis, enabling healthcare providers to efficiently choose the appropriate treatments for the individual patient. The Asia Pacific gene expression market growth is fuelled by such initiatives.

Increasing incorporation of cutting-edge technologies to yield most effective results in disease management and treatment is one of the major market trends. In November 2023, AstraZeneca and University of Cambridge expanded functional genomics partnership. At the university, scientists engaged in the utilization of advanced CRISPR technology to understand the genetic mechanisms better. This can lead to the development of effective treatment for multiple diseases including severe respiratory, cardiovascular, and metabolic diseases.

One of the significant Asia Pacific gene expression market trends include increased healthcare expenditure and investments to meet the rising demand for molecular diagnostics and personalized medicine. The expansion of health and pharmaceutical industry in emerging economies such as India, South Korea and Singapore has led to a greater demand for gene expression profiling. This can be attributed to increased incidence of drug discovery and development processes, which includes target identification, biomarker discovery, and preclinical studies.

Asia Pacific Gene Expression Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Asia Pacific Gene Expression Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• F. Hoffmann-La Roche Ltd

• QIAGEN

• Oxford Gene Technology (OGT) Group

• Eurofins Scientific

• LGC Limited

• Promega Corporation

• Takara Bio Inc.

• PacBio

• Smith & Nephew plc

• Abbott

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report